原发性卵巢功能不全女性乳腺癌风险增加
基于1995至2022年犹他州两家主要学术医疗系统记录的病例对照人群研究,纳入613例原发性卵巢功能不全(POI)女性,对比人群癌症发病率。POI女性乳腺癌风险升高(OR 2.20,95%CI 1.30-3.47,P=.0023),其二度亲属乳腺癌和结肠癌风险升高,一、二、三度亲属前列腺癌风险升高。数据提示POI与生殖系统癌症存在共同遗传风险。
要点
- POI女性乳腺癌风险升高(OR 2.20,95%CI 1.30-3.47,P=.0023)。
- POI女性二度亲属乳腺癌风险升高(OR 1.28,95%CI 1.08-1.52,P=.0078)。
- POI女性一、二、三度亲属前列腺癌风险均升高。
核心结论
- 数据提示POI与生殖系统癌症存在共同遗传风险。
- 需要工具来预测POI女性的癌症风险,并可能据此对激素替代治疗的风险进行咨询。
研究设计与样本
- 病例对照人群研究,使用1995年至2022年的记录。
- 设置:犹他州两家主要学术医疗系统,服务该州85%的人口。
- 研究对象:通过国际疾病分类编码识别并经准确性审查的POI女性613例,亲属通过犹他州人口数据库关联。
- 干预:通过犹他州癌症登记处识别癌症诊断。
- 主要结局指标:通过对比人群发病率估计POI女性及其亲属的癌症相对风险;对部分女性进行了全基因组测序。
主要发现
- POI女性乳腺癌风险升高(OR 2.20,95%CI 1.30-3.47,P=.0023),卵巢癌风险有名义上的显著升高。
- POI先证者诊断POI时年龄为36.5±4.3岁,诊断癌症时年龄为59.5±12.7岁。
- 鉴定出癌症和POI的致病性和候选基因变异。
- POI女性的二度亲属乳腺癌风险升高(OR 1.28,95%CI 1.08-1.52,P=.0078),结肠癌风险升高(OR 1.50,95%CI 1.14-1.94,P=.0036)。
- 前列腺癌风险在一度亲属(OR 1.64,95%CI 1.18-2.23,P=.0026)、二度亲属(OR 1.54,95%CI 1.32-1.79,P<.001)和三度亲属(OR 1.33,95%CI 1.20-1.48,P<.001)中均升高。
临床怎么用
- 作者认为需要工具来预测POI女性的癌症风险,并可能据此对激素替代治疗的风险进行咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: DNA damage/repair gene variants are associated with both primary ovarian insufficiency (POI) and cancer risk. OBJECTIVE: We hypothesized that a subset of women with POI and family members would have increased risk for cancer. DESIGN: Case-control population-based study using records from 1995 to 2022. SETTING: Two major Utah academic health care systems serving 85% of the state. SUBJECTS: Women with POI (n = 613) were identified using International Classification of Diseases codes and reviewed for accuracy. Relatives were linked using the Utah Population Database. INTERVENTION: Cancer diagnoses were identified using the Utah Cancer Registry. MAIN OUTCOME MEASURES: The relative risk of cancer in women with POI and relatives was estimated by comparison to population rates. Whole genome sequencing was performed on a subset of women. RESULTS: Breast cancer was increased in women with POI (OR, 2.20; 95% CI, 1.30-3.47; P = .0023) and there was a nominally significant increase in ovarian cancer. Probands with POI were 36.5 ± 4.3 years and 59.5 ± 12.7 years when diagnosed with POI and cancer, respectively. Causal and candidate gene variants for cancer and POI were identified. Among second-degree relatives of these women, there was an increased risk of breast (OR, 1.28; 95% CI, 1.08-1.52; P = .0078) and colon cancer (OR, 1.50; 95% CI, 1.14-1.94; P = .0036). Prostate cancer was increased in first- (OR, 1.64; 95% CI, 1.18-2.23; P = .0026), second- (OR, 1.54; 95% CI, 1.32-1.79; P < .001), and third-degree relatives (OR, 1.33; 95% CI, 1.20-1.48; P < .001). CONCLUSION: Data suggest common genetic risk for POI and reproductive cancers. Tools are needed to predict cancer risk in women with POI and potentially to counsel about risks of hormone replacement therapy.
引用
- Allen-Brady K, Moore B, Verrilli LE, et al. Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency. J Clin Endocrinol Metab. 2025. PMID: 38996041. doi:10.1210/clinem/dgae480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。